Kevin Joseph Fitzgerald

CSO & EVP, Head of Research, Alnylam Pharmaceuticals, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$9.6M

Companies

Latest trade

Mar 5, 2026

Companies

Alnylam Pharmaceuticals, Inc.CSO & EVP, Head of Research −$10.7M

Trades

ALNY Sold 658 shares at $323.98 · planned $0.2M Mar 5

ALNY Sold 633 shares at $323.08 · planned $0.2M Mar 4

ALNY Sold 1,652 shares at $319.73 · planned $0.5M Mar 3

ALNY Sold 1,598 shares at $327.65 · planned $0.5M Mar 2

ALNY Sold 2,041 shares at $331.96 · planned $0.7M Feb 17

ALNY Sold 1,959 shares at $310.08 · planned $0.6M Feb 13

ALNY Sold 2,290 shares at $370.33 · planned $0.8M Jan 13

ALNY Sold 1,510 shares at $362.87 · planned $0.5M Jan 12

ALNY Sold 12,128 shares at $452.18 · planned $5.5M Nov 17

ALNY Sold 2,441 shares at $452.05 $1.1M Oct 2

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.